Placebo Controlled Trial of Bosentan for SAPAH

ID Number 07-0598

Principal Investigator(s)
Maria L Padilla

Department(s) or Division(s)
Pulmonary, Critical Care and Sleep Medicine

Description

The purpose of this research study is to see if bosentan is safe and effective in the treatment of sarcoidosis associated pulmonary hypertension. The US Food and Drug Administration (FDA) have approved it for treatment of several forms of pulmonary hypertension. However, the use of bosentan in the treatment of sarcoidosis associated pulmonary hypertension is not approved by the FDA.



Contact Information
Olivera Calukovic
(212) 241-0059
olivera.calukovic@mssm.edu

Recruiting Patients: No